share_log

AngioDynamics Analyst Ratings

アンジオダイナミクスのアナリストレーティング

Benzinga ·  2023/10/05 14:29
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/05/2023 140.79% Canaccord Genuity $20 → $17 Maintains Buy
10/05/2023 183.29% HC Wainwright & Co. $19 → $20 Maintains Buy
09/25/2023 169.12% HC Wainwright & Co. → $19 Initiates Coverage On → Buy
07/13/2023 183.29% Canaccord Genuity $18 → $20 Maintains Buy
04/17/2023 84.14% Raymond James $14 → $13 Downgrades Strong Buy → Outperform
04/03/2023 98.3% Raymond James $22 → $14 Maintains Strong Buy
01/06/2023 211.61% Raymond James $25 → $22 Maintains Strong Buy
10/07/2022 254.11% Raymond James $27 → $25 Maintains Strong Buy
07/13/2022 282.44% Raymond James $32 → $27 Maintains Strong Buy
10/15/2021 424.08% Canaccord Genuity $28 → $37 Upgrades Hold → Buy
08/20/2021 Oppenheimer Initiates Coverage On → Perform
07/14/2021 296.6% Canaccord Genuity $24 → $28 Maintains Hold
07/09/2021 353.26% Raymond James $27 → $32 Maintains Strong Buy
03/31/2021 239.94% Canaccord Genuity $18 → $24 Maintains Hold
01/08/2021 239.94% Raymond James $18 → $24 Maintains Strong Buy
11/25/2020 154.96% Raymond James → $18 Upgrades Market Perform → Strong Buy
04/08/2020 98.3% Canaccord Genuity $18 → $14 Maintains Hold
04/08/2020 Keybanc Downgrades Overweight → Sector Weight
10/04/2019 197.45% Keybanc $30 → $21 Maintains Overweight
01/07/2019 225.78% Canaccord Genuity $20 → $23 Maintains Hold

What is the target price for AngioDynamics (ANGO)?

The latest price target for AngioDynamics (NASDAQ: ANGO) was reported by Canaccord Genuity on October 5, 2023. The analyst firm set a price target for $17.00 expecting ANGO to rise to within 12 months (a possible 140.79% upside). 8 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for AngioDynamics (ANGO)?

The latest analyst rating for AngioDynamics (NASDAQ: ANGO) was provided by Canaccord Genuity, and AngioDynamics maintained their buy rating.

When is the next analyst rating going to be posted or updated for AngioDynamics (ANGO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.

Is the Analyst Rating AngioDynamics (ANGO) correct?

While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a maintained with a price target of $20.00 to $17.00. The current price AngioDynamics (ANGO) is trading at is $7.06, which is out of the analyst's predicted range.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする